Treatment outcomes for children with cancer have made tremendous improvements in the past 50 years.  Certain childhood cancers, such as standard risk leukemia and a kidney tumor called Wilms' tumor, now have treatment success rates of more than 90%.  But despite great advances in how childhood cancer is treated, the reality is one in five children with cancer will still die of their disease within 5 years.

The Four Diamonds Research Institute

Founded in 1996, the Four Diamonds Research Institute is creating new knowledge to save the lives of children with cancer.  Our outstanding physician scientists and their teams are focused on learning more about how cancer forms, how it can be treated, and how treatments can be made to be more effective while minimizing long-term side effects of treatment.  As our research operation continue to grow, we remain committed to providing cutting edge medicine that uses the latest research findings in the care and treatment of patients.

As members of the Children's Oncology Group, our physicians and nurses are involved in the development and management of protocols used internationally to treat children with cancer.

Our research team is also a member of the Pediatric Oncology Experimental Therapeutics Investigators Consortium (POETIC) group, a network of 11 leading academic medical centers, all working together to provide the collaborative and research strength needed to complete intensive phase I and phase II clinical trials of novel cancer treatments.